The next direction for Alzheimer's disease treatments
Interviewee/Contributor
Jean-Claude Muller
Organisation
MedNous
Strategy
A new start for an amyloidosis therapy
Interviewee/Contributor
Pierre Vandepapelière
Organisation
Amyl Therapeutics BV
Novel antifungals set for market introduction
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Covid-19 and the future of diagnostics
Interviewee/Contributor
Neelam Patel
Organisation
MedCity
A new strategy for regenerating damaged tissue
Interviewee/Contributor
Tim Knotnerus
Organisation
AgomAb Therapeutics NV
Leyden Labs plans to protect against viral infections
Interviewee/Contributor
Koenraad Wiedhaup
Organisation
Leyden Laboratories BV
How exchange traded funds could benefit Europe
Interviewee/Contributor
Chris Maggos
Organisation
LifeSci Advisors
New technologies boost drug repurposing
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
The Bispecific Approach, Interviews with Merus, Genmab and NovalGen
Interviewee/Contributor
Bill Lundberg, Tahamtan Ahmadi and Amit Nathwani
Organisation
MedNous
Purespring to develop gene therapies for the kidney
Interviewee/Contributor
Richard Francis
Organisation
Purespring Therapeutics Ltd